Eagle Pharmaceuticals Inc Cash Flow Quality Index
Eagle Pharmaceuticals Inc cash flow quality index. Eagle Pharmaceuticals Inc (EGRX) has a Cash Flow Quality Index of -0.02x as of June 2023. Operating cash flow of $-126.00K is below net income of $5.16 Million, suggesting accrual-heavy earnings not yet converted to cash. See financial agility of Eagle Pharmaceuticals Inc to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of Eagle Pharmaceuticals Inc (2015–2020)
Cash flow quality index of Eagle Pharmaceuticals Inc from 2015 to 2020. Historical Cash Flow Quality Index for Eagle Pharmaceuticals Inc across 6 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore EGRX operating cash flow to total debt to assess how comfortably operating cash covers total debt obligations.
Eagle Pharmaceuticals Inc Cash Flow Quality Index by Year (2015–2020)
Eagle Pharmaceuticals Inc cash flow quality index by year from 2015 to 2020. Year-by-year earnings quality comparison for Eagle Pharmaceuticals Inc. For the full cash flow conversion analysis, see Eagle Pharmaceuticals Inc (EGRX) cash flow conversion.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2020 | 4.13x | $49.50 Million | $11.99 Million | ▲ +5.5% |
| 2019 | 3.91x | $55.99 Million | $14.31 Million | ▲ +138.2% |
| 2018 | 1.64x | $52.38 Million | $31.90 Million | ▲ +44.8% |
| 2017 | 1.13x | $58.92 Million | $51.94 Million | ▲ +73.6% |
| 2016 | 0.65x | $53.21 Million | $81.45 Million | ▲ +117.3% |
| 2015 | -3.78x | $-9.72 Million | $2.57 Million | — |